BIONOTE - Trademark Details
Status: 700 - Registered
Serial Number
88680678
Registration Number
6555859
Word Mark
BIONOTE
Status
700 - Registered
Status Date
2021-11-09
Filing Date
2019-11-05
Registration Number
6555859
Registration Date
2021-11-09
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
010905, 260115, 261701, 261706, 270301 - Atoms or molecular models. Three circles. Straight line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s). Geometric figures forming letters or numerals, including punctuation.
Published for Opposition Date
2020-04-07
Attorney Name
Law Office Assigned Location Code
N70
Employee Name
NIEMANN, SHELBY LYNN
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of the word "BIONOTE" in a stylized font. The first "O" in "BIONOTE" is connected with a line to a circle above it which is connected with another line to another circle above and to the left of it. Overall, the first "O" in "BIONOTE" and the circles connected by lines resemble a chemical structure.
Goods and Services
Downloadable computer software for capturing, reporting, and processing of data in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; recorded computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; downloadable mobile applications for generating patient-reported outcome reports in pharmaceutical industry clinical trials; downloadable software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, and for adding the aforementioned information to existing study questionnaires as a way to record concomitant medications
Goods and Services
Software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials; Software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on web based, short message service, and mobile devices; Software as a service (SAAS) services featuring software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient-reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; Software as a service (SAAS) services featuring software for interfacing and integrating with third-party clinical software systems to enable transferring, collecting, viewing, and sharing of clinical study data; Software as a service (SAAS) services featuring software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, and for adding the aforementioned information to existing study questionnaires as a way to record concomitant medications; providing online non-downloadable computer software for capturing, reporting, and processing of data in pharmaceutical industry clinical trials; providing online non-downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes in pharmaceutical industry clinical trials; providing online non-downloadable computer software for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of patient reported outcomes in pharmaceutical industry clinical trials on handhelds and PDAs; providing online non-downloadable software for enabling patients to select a medication from a list of their frequent medications, select a new drug or therapy, and enter all medication intake, and for adding the aforementioned information to existing study questionnaires as a way to record concomitant medications
Pseudo Mark
BIO NOTE
Classification Information
International Class
009 - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus. - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
US Class Codes
021, 023, 026, 036, 038
Class Status Code
6 - Active
Class Status Date
2019-11-12
Primary Code
009
First Use Anywhere Date
2020-11-01
First Use In Commerce Date
2020-11-01
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Camille M. Miller
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-11-08 | NEW APPLICATION ENTERED IN TRAM |
2019-11-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-11-13 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2020-02-10 | ASSIGNED TO EXAMINER |
2020-02-14 | NON-FINAL ACTION WRITTEN |
2020-02-14 | NON-FINAL ACTION E-MAILED |
2020-02-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-02-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-02-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-02-15 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-02-15 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2020-02-15 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2020-02-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-03-03 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-03-18 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-04-07 | PUBLISHED FOR OPPOSITION |
2020-04-07 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-06-02 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-11-09 | TEAS EXTENSION RECEIVED |
2020-11-09 | EXTENSION 1 FILED |
2020-11-09 | EXTENSION 1 GRANTED |
2020-11-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-01-13 | TEAS STATEMENT OF USE RECEIVED |
2021-02-02 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-01-13 | USE AMENDMENT FILED |
2021-02-03 | STATEMENT OF USE PROCESSING COMPLETE |
2021-02-24 | SU - NON-FINAL ACTION - WRITTEN |
2021-02-24 | NON-FINAL ACTION E-MAILED |
2021-02-24 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-05-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-07-09 | ASSIGNED TO LIE |
2021-07-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-08-10 | SU - FINAL REFUSAL - WRITTEN |
2021-08-10 | FINAL REFUSAL E-MAILED |
2021-08-10 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2021-08-17 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2021-08-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-08-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-10-05 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
2021-10-06 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
2021-11-09 | REGISTERED-PRINCIPAL REGISTER |